These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 973970)

  • 1. Rectal administration of feprazone in healthy volunteers.
    Ferrari P; Montanari C; Sala P; Vidi A
    Br J Clin Pharmacol; 1976 Apr; 3(2):339-40. PubMed ID: 973970
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of aluminium hydroxide on the bioavailability of feprazone. Single dose study.
    Spahn H; Mutschler E
    Arzneimittelforschung; 1985; 35(1):167-9. PubMed ID: 4039147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-pressure liquid chromatographic feprazone determination in pharmaceutical formulations.
    Bonora A; Borea PA
    J Pharm Sci; 1979 Jun; 68(6):798-800. PubMed ID: 458589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
    Morita K; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1986; 31(1):117-8. PubMed ID: 3780819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial of feprazone in ankylosing spondylitis.
    Harkness AJ; Burry HC; Grahame R
    Rheumatol Rehabil; 1977 Aug; 16(3):158-61. PubMed ID: 333540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gas chromatographic determination of Feprazone in medicinal preparations].
    Gallazzi A; Vanoni PC
    Farmaco Prat; 1975 Mar; 30(3):147-52. PubMed ID: 1204822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Topical treatment of thrombophlebitis with feprazone and benzydamine. Controlled clinical study].
    Bagliani A; Montalbetti L
    Minerva Med; 1976 Mar; 67(14):880-4. PubMed ID: 772478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD; Maisey MN; Grahame R; Burry HC
    Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas-chromatographic analysis of 4-prenyl-1,2-diphenyl-3-5-pyrazolidinedione (feprazone) at therapeutic levles in human plasma.
    Berry DJ
    J Chromatogr; 1975 Nov; 114(1):159-65. PubMed ID: 241756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial of feprazone and phenylbutazone in acute gout.
    Reardon JA; Stockman A; Darlington LG; Scott JT
    Curr Med Res Opin; 1980; 6(7):445-8. PubMed ID: 6988172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic injury following feprazone therapy.
    Wiggins J; Scott DL
    Rheumatol Rehabil; 1981 Feb; 20(1):44-5. PubMed ID: 6452677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
    Meloni T; Forteleoni G; Serra M; Daniotti S; Negri L; Giuntini P; Canepa L; Gaetani GF
    J Clin Pharmacol; 1982; 22(8-9):418-20. PubMed ID: 7130431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug.
    Koyama T; Izawa Y; Wada H; Makita T; Hashimoto Y; Enomoto M
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):255-70. PubMed ID: 7123554
    [No Abstract]   [Full Text] [Related]  

  • 14. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of feprazone and phenylbutazone interaction with warfarin in man.
    Chierichetti S; Bianchi G; Cerri B
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):568-72. PubMed ID: 810317
    [No Abstract]   [Full Text] [Related]  

  • 16. Some studies of feprazone.
    Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V
    Rheumatol Rehabil; 1976 May; 15(2):81-6. PubMed ID: 132695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feprazone compared with indomethacin in the management of rheumatoid arthritis.
    Sturrock R; Isaacs A; Hart FD
    Practitioner; 1975 Jul; 215(1285):94-7. PubMed ID: 1103113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miscellaneous rheumatological conditions treated in monitored-release studies with feprazone.
    Harris PG
    J Int Med Res; 1981; 9(4):248-52. PubMed ID: 6973494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of feprazone and phenylbutazone on testosterone hydroxylations in mouse hepatic microsomes.
    Morita K; Hayashi Y; Ono T; Shimakawa H
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):214-20. PubMed ID: 3698130
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombocytopenia and haemolytic anaemia due to feprazone.
    Bell PM; Humphrey CA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):17. PubMed ID: 6797620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.